Attached files
| file | filename |
|---|---|
| 10-Q - Altimmune, Inc. | v193710_10q.htm |
| EX-31.2 - Altimmune, Inc. | v193710_ex31-2.htm |
| EX-31.1 - Altimmune, Inc. | v193710_ex31-1.htm |
| EX-32.1 - Altimmune, Inc. | v193710_ex32-1.htm |
Exhibit 32.2
Certification
Pursuant to Section 1350 of Chapter 63
of
Title 18 of the United States Code
In
connection with the Quarterly Report of PharmAthene, Inc. (the “Company”)
on Form 10-Q for the quarter ended June 30, 2010, as filed with the
Securities and Exchange Commission (the “Report”), I, Charles A. Reinhart III,
Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that to the best of my knowledge:
|
1.
|
The
Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act
|
|
|
2.
|
The
information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the
Company.
|
|
|
/s/
Charles A. Reinhart III
|
|
|
Charles
A. Reinhart III
|
|
|
Chief
Financial Officer
|
|
|
August
13, 2010
|